(2001)7:1976–81. 11. Yamaguchi K, Enjoji M, Tsuneyoshi M. Pancreatoduodenal ca rcinoma: a clinicopathologic study of 304 patients and immunohistochemical observation for CEA and CA19-9. J Surg Oncol. (1991) 47:148–54. doi:10.1002/jso.2930470303 12. Komoto M, Nakata B, Amano R, Yamada N, Yashiro M, Ohira M, et al. HER2 overexpression correlates with survival after curative resection of pancreatic cancer. Cancer Sci. (2009) 100:1243–7. doi:10.1111/j.1349-7006.2009.01176.x 13. Maacke H, Kessler A, Schmiegel W, Roeder C, Vogel I, Deppert W, et al. Overexpression of p53 protein during pancreatitis. Br J Cancer. (1997) 75:1501–4.doi:10.1038/bjc.1997.256 14. CappelloP,TomainoB,ChiarleR,CerutiP,NovarinoA,CastagnoliC, etal. An integrated humoral and cellular response is elicited in pancreatic ca ncer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-asso ciated antigen.IntJCancer. (2009)125:639–48.doi:10.1002/ijc.24355 15. Wachsmann MB, Pop LM, Vitetta ES. Pancreatic ductal adenoc arcinoma: a review of immunologic aspects. J Invest Med. (2012) 60:643–63. doi:10.2310/JIM.0b013e31824a4d79 16. Foucher ED, Ghigo C, Chouaib S, Galon J, Iovanna J, Olive D. P ancreatic ductaladenocarcinoma:astrongimbalanceofgoodandbadimmunolog ical cops in the tumor microenvironment. Front Immunol. (2018) 9:1044. doi:10.3389/ﬁmmu.2018.01044 17. von Bernstorﬀ W, Voss M, Freichel S, Schmid A, Vogel I, Johnk C , et al. Systemic and local immunosuppression in pancreatic cancer patients. Clin CancerRes. (2001)7(3Suppl.):925s −32s.18. Schmidt J, Mocevicius P, Werner J, Ryschich E. The role of the t umor endothelium in leukocyte recruitment in pancreatic cancer. Surgery.(2012) 152(3Suppl1.):S89–94.doi:10.1016/j.surg.2012.05.027 19. Guerra C, Collado M, Navas C, Schuhmacher AJ, Hernández-Porras I, Cañamero M, et al. Pancreatitis-induced inﬂammation contributes t o pancreatic cancer by inhibiting oncogene-induced senescenc e.Cancer Cell. (2011)19:728–39.doi:10.1016/j.ccr.2011.05.011 20. Ino Y, Yamazaki-Itoh R, Shimada K, Iwasaki M, Kosuge T, Kana i Y, et al. Immune cell inﬁltration as an indicator of the immune microenvironment of pancreatic cancer. Br J Cancer. (2013) 108:914–23. doi: 10.1038/bjc. 2013.32 21.